The largest database of trusted experimental protocols

Genespring software version 14

Manufactured by Agilent Technologies
Sourced in United States

GeneSpring software version 14.5 is a bioinformatics software tool developed by Agilent Technologies. It provides a platform for the analysis and visualization of genomic data, including gene expression data from microarray and next-generation sequencing experiments.

Automatically generated - may contain errors

6 protocols using genespring software version 14

1

Differential Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analyses were performed by using GeneSpring software version 14.5 (Agilent Technologies, Inc., Santa Clara, CA). A paired t-test compared the “before” and “after” treatment samples. A statistical threshold of p < 0.05 with fold-change (FC) ≥ 2 was considered as significant for identification of differentially expressed genes. The probe set signals were calculated with the Iterative Plier 16 summarization algorithm; baseline to median of all samples was used as baseline option.
+ Open protocol
+ Expand
2

Differential Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analyses were performed by using GeneSpring software version 14.5 (Agilent Technologies, Inc., Santa Clara, CA). A paired t-test compared the “before” and “after” treatment samples. A statistical threshold of p < 0.05 with fold-change (FC) ≥ 2 was considered as significant for identification of differentially expressed genes. The probe set signals were calculated with the Iterative Plier 16 summarization algorithm; baseline to median of all samples was used as baseline option.
+ Open protocol
+ Expand
3

Comparative Analysis of SDPP Diets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data on growth performance, feed conversion and skin morpohometrics were compared by means of a t-test. Regarding, microarray data, an unpaired t-test) was conducted using the GeneSpring software GX 14.5 to detect DEGs (p < 0.05) between the control and SDPP groups. Mucus differential synthesized proteins (DESs) that were found to vary in their abundance between the control and SDPP diets were analyzed for significance using a t-test. The Shapiro-Wilk test was first used to ensure the normal distribution of the data, while the uniformity of the variances was determined by Levene’s test. The DEGs and DESs fold-change graphs were represented with GraphPad software version 7.0. The PCA analyses for DEGs and DESs were obtained from GeneSpring software version 14.5 (Agilent Technologies) and Analyse-it Software versión 5.4, respectively.
+ Open protocol
+ Expand
4

Microarray Analysis of SDPP Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
An unpaired t-test was conducted for microarrays data using the GeneSpring software GX 14.5 to detect DEGs (p < 0.05) between the control and SDPP groups. The DEGs were represented with GraphPad software version 7.0. The PCA analysis and the heatmap for DEGs were obtained from GeneSpring software version 14.5 (Agilent Technologies). The hierarchical map was clustered by the normalized intensity values (p < 0.05), with Euclidean distance and Ward linkage.
+ Open protocol
+ Expand
5

miRNA Profiling of Plasma Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
miRNA profile analysis of the plasma samples was performed using a miRNA Microarray Chip V2.4 (Agilent Technologies, Inc.), which contains probes for 2,549 human miRNAs with a sample input of 100 ng total RNA. Briefly, dephosphorylation was performed by gently mixing the total RNA with 2 µl calf intestinal alkaline phosphatase master mix (Agilent Technologies, Inc.) and incubating the mixture at 37°C in a circulating water bath for 30 min. Subsequently, 2.8 µl 100% dimethyl sulfoxide was added to each sample and incubated at 100°C in a circulating water bath for 5–10 min for denaturation. The samples were labeled using a miRNA Complete Labeling and Hybridization kit and hybridized on an Agilent SureHyb Microarray Hybridization Chamber (both from Agilent Technologies, Inc.). Following hybridization, the chip was washed using GE wash buffer 1 and GE wash buffer 2 (Gene Expression Wash Buffer kit; cat. no. 5188–5327; Agilent Technologies, Inc.). The chip was scanned and the data were extracted using Agilent Feature Extraction Software version 10.7.1.1 (Agilent Technologies, Inc.). Data were standardized using GeneSpring Software version 13.1 (Agilent Technologies, Inc.). Fold change ≥2 and P<0.05 were used to indicate significant differences in gene expression, and cluster analysis was performed using Genespring software version 14.8 (Agilent Technologies, Inc.).
+ Open protocol
+ Expand
6

Comprehensive miRNA Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected in BD Vacutainer K2EDTA tubes using a 21-gauge needle. PBMC were obtained upon stratification on Lympholyte® cell separation density gradient (Cedarlane, Burlington, Canada). Total RNA extraction from PBMCs was performed with miRNeasy mini kit following manufacturer's protocol (Qiagen GmbH, Hilden, Germany). Samples hybridization and scanning were performed with miRNA Complete Labeling and Hyb Kit Protocol manual following the manufacturer provided protocols (Agilent Technologies, SantaClara, CA, USA), by the Cancer Genomics Laboratory of Edo ed Elvo Tempia Valenta foundation (Fondazione Edo ed Elvo Tempia Valenta, Biella, Italy). SurePrint Human miRNA Microarray Kit Release 21.0, 8x60K (Agilent Technologies), containing probes for 2549 miRNAs, was used. The Gene Spring software, version 14.8 (Agilent Technologies, SantaClara, CA, USA), was used to background-adjust, normalize, and log-transform signals intensity. Quantile was used for between-array normalization. Relative miRNAs expression levels were validated applying the unpaired t-test (p ≤ 0.01) and the Bonferroni multiple testing correction. Finally, statistically significant miRNAs were chosen for final consideration when their expression was at least 1.5-fold different in the test sample versus control sample [log2(fold change) > |0.5|].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!